Form 4: I-Mab Director Reports Stock Transaction
Insider Transaction (Form 4)
Robert A. Lenz, a Director of I-Mab, reported multiple transactions in common stock on August 22, 2026.
Summary
- Option exercise/conversion: acquired 17,218 Ordinary Shares on August 22, 2026; holds 17,218 after (Direct).
- Option exercise/conversion: disposed of 7,486 Restricted Share Units on August 22, 2026; holds 14,974 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Robert A. Lenz — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-22 | Option exercise/conversion | Ordinary Shares | 17,218 | — | — | 17,218 |
| 2026-08-22 | Option exercise/conversion | Restricted Share Units | 7,486 | — | — | 14,974 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-22 | Option exercise/conversion (17,218 shares) |
| 2026-08-22 | Option exercise/conversion (7,486 shares) |
Keywords
insider transaction, Form 4, NBP, NovaBridge Biosciences, neutral, Robert A. Lenz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.